Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases


1 Laboratory of Molecular Oncology, Cancer Research Institute of Slovak Academy of Sciences, Vlarska 7, Bratislava 833 91, Slovakia

2 Institute of Pathological Anatomy, Faculty of Medicine, Comenius University, Sasinkova 4, Bratislava 813 72, Slovakia

For all author emails, please log on.